Lupron and Creon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lupron (leuprolide acetate) and Creon (pancrelipase (amylase;lipase;protease)). Common drug interactions include cellulitis among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lupron and Creon. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Lupron?

Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

27 people who take Lupron and Creon together, and have interactions are studied.

Lupron and Creon drug interactions.

What are the common drug interactions of Lupron and Creon, by gender? *:

female:

  1. Cellulitis (infection under the skin)
  2. Folliculitis (infection of hair root)
  3. Pyrexia (fever)
  4. Rash papular (redness with papule)
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Hot flush (sudden feelings of heat)
  8. Vaginal haemorrhage (vaginal bleeding)
  9. Cataract (clouding of the lens inside the eye)
  10. Anxiety

male:

  1. Death
  2. Asthenia (weakness)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Drug hypersensitivity
  5. Gait disturbance
  6. Hemiparesis (weakness on one side of the body)
  7. Impaired work ability
  8. Muscle atrophy (a decrease in the mass of the muscle)
  9. Precancerous cells present
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the common drug interactions of Lupron and Creon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hepatic enzyme increased

10-19:

n/a

20-29:

  1. Anxiety
  2. Back pain
  3. Headache (pain in head)
  4. Hot flush (sudden feelings of heat)
  5. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  6. Mood swings (an extreme or rapid change in mood)
  7. Muscle spasms (muscle contraction)
  8. Pain
  9. Vaginal haemorrhage (vaginal bleeding)

30-39:

  1. Abdominal pain
  2. Abscess (pus)
  3. Blood oestrogen decreased
  4. Chest discomfort
  5. Constipation
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Frequent bowel movements
  8. Haemoglobin decreased
  9. Hypertension (high blood pressure)
  10. Injection site cyst

40-49:

  1. Post procedural infection
  2. Thyroid cancer

50-59:

  1. Cellulitis (infection under the skin)
  2. Folliculitis (infection of hair root)
  3. Pyrexia (fever)
  4. Rash papular (redness with papule)
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Cataract (clouding of the lens inside the eye)
  8. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  9. Blood pressure decreased
  10. Death

60+:

  1. Asthenia (weakness)
  2. Fatigue (feeling of tiredness)
  3. Muscle atrophy (a decrease in the mass of the muscle)
  4. Pneumonia
  5. Precancerous cells present
  6. Prostatic specific antigen increased
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Weight decreased
  9. Weight increased
  10. Abasia (inability to walk)

What are the existing conditions these people have? *

  1. Prostate Cancer: 9 people, 33.33%
  2. Pain: 8 people, 29.63%
  3. Hypersensitivity: 7 people, 25.93%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 18.52%
  5. Rashes (redness): 5 people, 18.52%
  6. Indigestion: 5 people, 18.52%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 18.52%
  8. Cystic Fibrosis (disease of the secretary glands): 4 people, 14.81%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
  10. Acne (skin problems that cause pimples): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Lupron and Creon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lupron and Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lupron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lupron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate and pancrelipase (amylase;lipase;protease) (the active ingredients of Lupron and Creon, respectively), and Lupron and Creon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: